Corepharma

CorePharma is a leading U.S-based contract development and manufacturing organization (CDMO), dedicated to delivering high-quality pharmaceuticals across diverse therapeutic categories. We provide comprehensive, end-to-end solutions—from early-stage drug development to commercial launch and beyond. With a proven track record of regulatory excellence, CorePharma operates 4 state-of-the-art, FDA- and DEA-registered facilities, spanning square feet. Our advanced development, analytical, clinical, and commercial manufacturing and packaging capabilities support an annual production capacity of 5 billion dosage units. Backed by industry-leading lead times, we accelerate your journey from the lab to the clinic—and ultimately to the patient. At CorePharma, we are committed to being your concept to commercial CDMO platform for success.